Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Helsinn Therapeutics (U.S.), Inc
Helsinn Therapeutics (U.S.), Inc
Industry · 10 registered clinical trials.
Status
Trial
Phase
Started
Completed
Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnos
Mycosis Fungoides
—
2014-11-12
Completed
Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2)
Cachexia, Non-Small Cell Lung Cancer
Phase 3
2011-07-01
Completed
Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1)
Cachexia, Non-Small Cell Lung Cancer
Phase 3
2011-07-01
Completed
Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3
Cachexia, Non-Small Cell Lung Cancer
Phase 3
2011-07-01
Completed
Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function
Gastrointestinal Dysmotility
Phase 2
2011-04-01
Completed
Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
Ileus
Phase 2
2008-04-01
Completed
Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Phase 2
2008-03-01
Completed
Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia
Cancer Cachexia
Phase 2
2006-09-01
Completed
Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.
Cancer Cachexia
Phase 2
2005-11-01
Completed
Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss
Cancer Cachexia
Phase 2
2005-06-01